Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
< Previous
1
2
3
Next >
Cannabis-Based Dronabinol Could Transform Alzheimer's Care, New Study Finds
October 06, 2024
Tickers
NEWS
Tags
Top Stories
Markets
News
From
Benzinga
Shark Tank's Barbara Corcoran Reveals Her Struggle With Alzheimer's In Her Family
September 28, 2024
Tickers
NEWS
Tags
Psychology
Health Care
AI Generated
From
Benzinga
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
US: News
Pharmaceuticals
Health & Science
From
CNBC.com News
Midsummer News Flashes – Good and Not So Good
August 14, 2024
Tags
Doc Gumshoe
tattoo
Alzheimer's Disease
From
Stock Gumshoe
Alzheimer’s and Parkinson’s Tests and Treatments… plus a Quick COVID-19 (and Long COVID) Update
July 25, 2024
Tags
Alzheimer's Disease
Doc Gumshoe
coronavirus
From
Stock Gumshoe
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
July 09, 2024
Tickers
ALS
NEWS
WENA
Tags
Stories That Matter
WENA
ALS
From
Benzinga
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
July 03, 2024
Tickers
LLY
NEWS
Tags
Stories That Matter
Market News
Pooja Rajkumari
From
Benzinga
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
Tags
Alzheimer's disease
Paramount Global
Oil and Gas
From
CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
Tags
Tesla Inc
Eli Lilly and Co
Electric vehicles
From
CNBC.com News
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
June 21, 2024
Tags
cannabinoid
Top Stories
Expert Ideas
From
Benzinga
Op-ed: An Alzheimer’s wave is coming. Here's how to protect your family and your finances
February 09, 2024
Tags
Health Care Services
Health Insurance
Alzheimer's disease
From
CNBC.com News
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
Biotech
Briefs
News
From
Benzinga
Could CBD Revolutionize Alzheimer's Treatment? New Study Explores Its Neuroprotective Properties
December 04, 2023
Tickers
CBD
Tags
China Pharmaceutical University study
CBD
News
From
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Tickers
ACIU
BIIB
ESAIY
ESALY
Tags
ACIU
pharmaceuticals
PRTA
From
Benzinga
The MIND diet is touted for its brain-boosting benefits—but can it really lower risk of dementia?: What a neurologist thinks
September 30, 2023
Tags
Make It
Dementia
Diets and dieting
From
CNBC.com News
Autism Therapy: Cannformatics Targets Metabolic Imbalances Using Machine Learning
August 24, 2023
Tickers
TECH
Tags
Markets
multiple sclerosis
Startups
From
Benzinga
Bill Gates used to think this habit was lazy and 'unnecessary'—now it's his No. 1 key for a healthy brain
August 03, 2023
Tags
Make It
Make It / Power Players
Microsoft Corp
From
CNBC.com News
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
Tickers
POTX
TOKE
Tags
POTX
FDA
Benzinga
From
Benzinga
Medicare Part B premiums may increase in 2024, prompted by a new Alzheimer's treatment
July 20, 2023
Tags
Elder care insurance
Retiree finances
Health care costs
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Social issues
US: News
U/S/ Economy
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Pharmaceuticals
Law and Regulation
Health & Science
From
CNBC.com News
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
July 07, 2023
Tickers
ALZN
BIIB
LLY
SAVA
Tags
Health Care
BIIB
Small Cap
From
Benzinga
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Breaking News: Business
Business News
Science
From
CNBC.com News
Alzheimer’s Disease, RSV, Migraines and more…
June 22, 2023
Tags
GlaxoSmithKline (GSK)
H/ Lundbeck (HLBBF HLUBF)
Novartis (NVS)
From
Stock Gumshoe
Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
June 21, 2023
Tags
Benzinga
Market News
cannabinoid therapeutics
From
Benzinga
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Biotech and Pharmaceuticals
Alzheimer's disease
Biotechnology
From
CNBC.com News
Medicare details plan to cover Alzheimer's treatments
June 01, 2023
Tags
Policy
Health & Science
U/S/ Economy
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Business
Biogen Inc
Health care industry
From
CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
US: News
Eli Lilly and Co
US Economy
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.